• New Launches

Cadila Pharmaceuticals launches biosimilar Rituximab drug Ritucad™

Ahmedabad, July 29, 2020: Ahmedabad-based Cadila Pharmaceuticals Limited recently announced the launch of biosimilar Rituximab for India market. Biosimilar Rituximab…

Interleukin-17 Inhibitor Shows High Efficacy After One Year of Therapy in Psoriasis Patients

New Delhi, April 28, 2018: In March 2018, BIOCAD analyzed results from its Phase II study in which the original…